Nilotinib Versus Nilotinib Combined to Pegylated Interferon-Alpha2a as First-Line Therapy in Chronic Phase Chronic Myeloid Leukaemia. Final Results of the National Academic Phase Iii Petals Trial Article Swipe

Franck E. Nicolini , Gabriel Étienne , Françoise Huguet , Aude Charbonnier , Gabrielle Roth-Guépin , Martine Escoffre‐Barbe , Viviane Dubruille , Hyacinthe Johnson‐Ansah , Philippe Rousselot , Laurence Legros , Anne Parry , Lydia Roy , Valérie Coiteux , Pascal Lenain , Jean‐Christophe Ianotto , Charlotte Doublet , Corentin Orvain , Marion Simonet‐Boissard , Marie‐Lorraine Chrétien , Amélie Penot , Mathieu Meunier , Shanti Amé , Éric Hermet , Philippe Quittet , Simona Lapusan , Vérane Schwiertz , Jean-Michel Cayuela , Carole Mauté , Delphine Réa , Stéphane Morisset , François-Xavier Mahon , Stéphanie Dulucq · YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.2139/ssrn.5386791